KraneShares MSCI All China Health Care Index ETF (KURE)

NYSEARCA: KURE · IEX Real-Time Price · USD
-0.77 (-3.21%)
Jan 31, 2023, 4:00 PM EST - Market closed
Assets $114.58M
Expense Ratio 0.65%
PE Ratio 24.62
Shares Out 4.80M
Dividend (ttm) $0.01
Dividend Yield 0.04%
Ex-Dividend Date Dec 28, 2022
Payout Ratio 1.10%
1-Year Return -6.65%
Volume 90,077
Open 23.36
Previous Close 23.99
Day's Range 23.05 - 23.36
52-Week Low 16.67
52-Week High 25.11
Beta 0.46
Holdings 86
Inception Date Feb 1, 2018

About KURE

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

Asset Class Equity
Category China Region
Region Asia-Pacific
Stock Exchange NYSEARCA
Ticker Symbol KURE
Issuer Website KraneShares
Index Tracked MSCI China All Shares Health Care 10/40

Top 10 Holdings

45.09% of assets
Name Symbol Weight
WuXi Biologics (Cayman) Inc 2269.HK 8.46%
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A 300760.SZ 7.02%
BeiGene Ltd Ordinary Shares 6160.HK 4.71%
Jiangsu Hengrui Pharmaceuticals Co Ltd Class A 600276.SS 4.62%
CSPC Pharmaceutical Group Ltd 1093.HK 4.06%
Wuxi AppTec Co Ltd Class A 603259.SS 4.05%
Aier Eye Hospital Group Co Ltd Class A 300015.SZ 4.00%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A 600436.SS 3.30%
Chongqing Zhifei Biological Products Co Ltd Class A 300122.SZ 2.60%
Sino Biopharmaceutical Ltd 1177.HK 2.26%
View More Holdings


Ex-Dividend Amount Pay Date
Dec 28, 2022 $0.0104 Dec 30, 2022
Dec 29, 2021 $4.05345 Dec 31, 2021
Dec 29, 2021 $0.00009 Dec 31, 2021
Dec 29, 2020 $0.00011 Dec 31, 2020
Dec 27, 2019 $0.05733 Dec 31, 2019
Dec 26, 2018 $0.03934 Dec 28, 2018
Full Dividend History


China Growth Outlook Could Boost This ETF in 2023

China might not deliver GDP growth on par with the rates seen during the halcyon days of emerging markets investing earlier this century, but the world's second-largest economy could finally be an all...

2 weeks ago - ETF Trends

Foreign Investors Flooding Back into China

Foreign investors are pouring back into China after having been underweight for much of the last year and a half. Over $1.85 billion flowed into Mainland stocks via the Northbound Stock Connect, and i...

Other symbols: KALLKBA
3 weeks ago - ETF Trends

Why China's Healthcare Sector Might be the Real Reopening Play

China continues to roll back its COVID-19 zero-tolerance policy, lifting many ongoing quarantines and removing testing requirements that previously prevented the population from moving about cities an...

1 month ago - ETF Trends

China ETFs Rallying: Top Gainers Past Month

China ETFs have been rallying of late to reflect easing Covid controls and a sweeping rescue package to bail out developers.

2 months ago - Zacks Investment Research

KURE Could Be Interesting Play Following China Party Congress

China is in the midst of its week-long Party Congress, which was started Sunday with President Xi's two-hour speech, it hasn't been the market-moving event some investors were hoping for, but there ar...

3 months ago - ETF Trends

This Week's Top Performing ETFs: 06/19/2022

Top Performing Unleveraged ETFs Last Week These were last week's top-performing ETFs. We've excluded funds that use leverage or make inverse bets on their underlying assets.

7 months ago - ETF Trends

Valuation Opportunities Abound Within China's Healthcare Sector

The health care industry in China is expected to expand rapidly in the coming years with a rapidly aging population, growing infrastructure, and China's growing role in the global health care system t...

9 months ago - ETF Trends

KraneShares Debuts Umbrella China ETF

The newest ETF is a fund-of-funds composed of existing China ETFs.

1 year ago - ETFcom

A KURE-All for Bland Healthcare Exposure

In some form or fashion, hundreds of exchange traded funds offer exposure to Chinese equities. As the world's second-largest country has evolved, so have the related ETF offerings.

1 year ago - ETF Trends

Healthcare Gains Drive Chinese Stocks Even Higher

Asian markets ended last week up, buoyed in part by a rally in healthcare firms, according to Reuters. The blue-chip CSI300 Index, which tracks the top 300 stocks traded on the Shenzhen Stock Exchange...

1 year ago - ETF Trends

Cover All the Hot Bases in Chinese Equity with This Model Portfolio

ETF investors looking for growth and innovation in China, can turn to the KraneShares Krane China Innovation Strategy. The strategy consists of a model portfolio that seeks to provide investors exposu...

1 year ago - ETF Trends

5 Top-Performing ETFs of Last Week

Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.

Other symbols: CHBCHIHEPU
1 year ago - Zacks Investment Research

Is Chinese Healthcare the Miracle KURE for Your Portfolio?

In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between. China offers a comparable level of healthcare dynamism, which in...

1 year ago - ETF Trends

Best Pharmaceutical ETFs for Q2 2021

The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.

Other symbols: POTX
2 years ago - Investopedia

China Continues to Be Risky for Investors. What to Expect in 2021.

China risks are on multiple fronts—from the technology rivalry with the U.S. to more regulatory scrutiny inside China of internet giants.

Other symbols: CHIQCXSEKWEB
2 years ago - Barrons

Best Healthcare ETFs for Q1 2021

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Other symbols: ARKGPTH
2 years ago - Investopedia

Best Pharmaceutical ETFs for Q1 2021

The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.

Other symbols: IHEXPH
2 years ago - Investopedia

The Tell: China's bouncing back, but don't bet on other emerging markets to join the ride

China's economy is bouncing back, but other emerging markets aren't likely to enjoy the spoils, says one economist.

2 years ago - Market Watch

Chinese stocks have biggest gains in 3 months

Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.

Other symbols: CNXTKWEB
2 years ago - Yahoo Finance

COVID Impact Varies Across Emerging Market ETFs

Emerging markets have been hit hard by coronavirus, but some were hit harder than others.

2 years ago - ETFcom

Best Healthcare ETFs for Q4 2020

The best healthcare ETFs for Q4 2020 are ARKG, KURE, and PTH.

Other symbols: ARKGPTH
2 years ago - Investopedia

Best Pharmaceutical ETFs for Q4 2020

The best pharmaceutical ETFs for Q4 2020 are KURE, XPH, and PJP.

Other symbols: PJPXPH
2 years ago - Investopedia

Top 10 Sector ETFs on the Market Today

Sector ETFs and industry funds are different. The 11 sectors addressed in the S&P 500 are as follows (in order of weight in the index): technology, healthcare, consumer discretionary, communication se...

2 years ago - InvestorPlace

5 Reasons to Bet on China ETFs

The Chinese economy returned to growth in the second quarter of 2020. This along with PBOC's targeted policy easing and China's solid tech industry make China investing winners in the recent trading s...

Other symbols: ASHSCHISCNXT
2 years ago - Zacks Investment Research

6 China ETFs From 3 Sectors That Emerged Winners in June

A host of China ETFs outperformed in June. These funds come mainly from the technology, healthcare and clean energy segments.

2 years ago - Zacks Investment Research